Dana-Farber News (@DanaFarberNews) “Next-generation HIF-2α inhibitor casdatifan shows promising signs of on-target e” — TopicDigg
Dana-Farber News
@DanaFarberNews
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu
加入 April 2018
611 正在关注 6.2K 粉丝
Next-generation HIF-2α inhibitor casdatifan shows promising signs of on-target efficacy in first-in-patient clinical trial in metastatic clear cell kidney cancer. Now published in @Nature and led by @DrChoueiri. @DanaFarber_GU
➡️
显示更多
